Literature DB >> 21826622

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: 7-year follow-up of a rare clinicopathologic syndrome.

R F Falkenstern-Ge1, M Kimmich, G Friedel, A Tannapfel, V Neumann, M Kohlhaeufl.   

Abstract

BACKGROUND: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare clinical pathological syndrome. There have been only 49 cases of DIPNECH reported in the literature so far. We report a case of a 69-year-old nonsmoking man with a 7-year follow-up.
METHODS: The initial CT scan from December 2003 showed persistent nonspecific bilateral reticulonodular infiltrates. In January 2004, the patient underwent a video-assisted thoracoscopic wedge resection of his right lower lobe for further diagnostic workup. Pathology of the resected wedge of the right lower lobe revealed a diffuse idiopathic pulmonary cell hyperplasia (DIPNECH) highlighted by staining for the neuroendocrine typical carcinoid markers, such as marker CD 56.
RESULTS: All the performed CT scans over a 7-year period showed no progression of the bilateral pulmonary lesion. The bilateral pulmonary nodules were stable in terms of size, number and form. The yearly control with chest CT scans will be continued.
CONCLUSIONS: The neuroendocrine cell hyperplasia is confined to the airway mucosa without penetration through the basement membrane and appears in a diffuse pattern, generally in close association with obliterative bronchiolar fibrosis. DIPNECH is characterized by a mixed obstructive and/or restrictive ventilation pattern with bilateral reticulonodular infiltrates and a predilection for middle-aged women. Little is known about the clinical course and treatment for DIPNECH.

Entities:  

Mesh:

Year:  2011        PMID: 21826622     DOI: 10.1007/s00432-011-1015-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  8 in total

1.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and a typical carcinoid tumor.

Authors:  Elizabeth Chittilappilly Johney; Joachim Pfannschmidt; Ralf Joachim Rieker; Philipp Albert Schnabel; Gunhild Mechtersheimer; Hendrik Dienemann
Journal:  J Thorac Cardiovasc Surg       Date:  2006-05       Impact factor: 5.209

Review 2.  Pulmonary preinvasive neoplasia.

Authors:  K M Kerr
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

3.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease.

Authors:  Susan J Davies; John R Gosney; David M Hansell; Athol U Wells; Roland M du Bois; Margaret M Burke; Mary N Sheppard; Andrew G Nicholson
Journal:  Thorax       Date:  2006-11-10       Impact factor: 9.139

4.  Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors.

Authors:  R R Miller; N L Müller
Journal:  Am J Surg Pathol       Date:  1995-06       Impact factor: 6.394

5.  The role of interferons in the management of carcinoid tumors.

Authors:  K Oberg; B Eriksson
Journal:  Acta Oncol       Date:  1991       Impact factor: 4.089

6.  Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors.

Authors:  L Saltz; B Trochanowski; M Buckley; B Heffernan; D Niedzwiecki; Y Tao; D Kelsen
Journal:  Cancer       Date:  1993-07-01       Impact factor: 6.860

Review 7.  Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms.

Authors:  V E Gould; R I Linnoila; V A Memoli; W H Warren
Journal:  Lab Invest       Date:  1983-11       Impact factor: 5.662

8.  High expression of neutral endopeptidase in idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells.

Authors:  A J Cohen; T E King; L B Gilman; C Magill-Solc; Y E Miller
Journal:  Am J Respir Crit Care Med       Date:  1998-11       Impact factor: 21.405

  8 in total
  3 in total

Review 1.  Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.

Authors:  Eric Wirtschafter; Ann E Walts; Sandy T Liu; Alberto M Marchevsky
Journal:  Lung       Date:  2015-06-24       Impact factor: 2.584

2.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with a central and peripheral carcinoid and multiple tumorlets: a case report emphasizing the role of neuropeptide hormones and human gonadotropin-alpha.

Authors:  Hanako Oba; Kazunori Nishida; Shingo Takeuchi; Hirohiko Akiyama; Koji Muramatsu; Masafumi Kurosumi; Toru Kameya
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

3.  Diffuse intrapulmonary neuroendocrine cell hyperplasia.

Authors:  Anna Louise McGuire; Donna E Maziak; Harman S Sekhon
Journal:  Can Respir J       Date:  2013-09-12       Impact factor: 2.409

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.